Observational studyDiabetes, obesity & metabolism2017

Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes.

Thomas Nyström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.